Drug anticancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Tumor Cells, Cultured HT29 Cells HCT116 Cells MCF-7 Cells HL-60 Cells Hep G2 Cells KB Cells HeLa Cells K562 Cells Mitochondria Cell Line

Organisms12

Mice, Nude Mice, Inbred BALB C Oplopanax Mice, SCID Plants, Medicinal Scutellaria baicalensis Taxus Oncolytic Viruses Withania Mice, Inbred C57BL Tylophora Undaria

Diseases16

Neoplasms Breast Neoplasms Colonic Neoplasms Lung Neoplasms Neoplasms, Experimental Leukemia P388 Prostatic Neoplasms Leukemia L1210 Melanoma, Experimental Neovascularization, Pathologic Adenocarcinoma Ovarian Neoplasms Liver Neoplasms Melanoma Carcinoma, Hepatocellular Pancreatic Neoplasms

Chemicals and Drugs138

Antineoplastic Agents Antineoplastic Agents, Phytogenic Doxorubicin Antibiotics, Antineoplastic Plant Extracts Drug Carriers Cisplatin Prodrugs Camptothecin Ellipticines Anticarcinogenic Agents Paclitaxel Etoposide Enzyme Inhibitors P-Glycoprotein Topoisomerase I Inhibitors Topoisomerase Inhibitors Caspases Tubulin Modulators Caspase 3 DNA Topoisomerases, Type II Antimetabolites, Antineoplastic Triterpenes Xanthones Proto-Oncogene Proteins c-bcl-2 Tumor Suppressor Protein p53 Curcumin Platinum Histone Deacetylase Inhibitors Coordination Complexes Intercalating Agents Daunorubicin Angiogenesis Inhibitors Nanocapsules Antineoplastic Agents, Alkylating Drugs, Investigational Stilbenes Fluorouracil Biological Products Naphthoquinones RNA, Small Interfering Reactive Oxygen Species Noscapine Piperidones Organoplatinum Compounds Neoplasm Proteins Indoles Benzoquinones Sesquiterpenes Ruthenium Mitomycin Boronic Acids DNA Pyrazines Mitoxantrone Hydroxamic Acids Proteasome Inhibitors Protein Kinase Inhibitors DNA Topoisomerases, Type I Sulfonamides Anthracyclines Thiosemicarbazones Anthraquinones DNA Adducts Thiazoles bcl-2-Associated X Protein TNF-Related Apoptosis-Inducing Ligand Multidrug Resistance-Associated Proteins Depsipeptides Naphthalimides Radiation-Sensitizing Agents TOR Serine-Threonine Kinases Liposomes Razoxane Flavonoids Poly(ADP-ribose) Polymerases Proto-Oncogene Proteins c-akt HSP90 Heat-Shock Proteins Antioxidants RNA, Messenger Lactams, Macrocyclic Apigenin Silymarin Apoptosis Regulatory Proteins Organoselenium Compounds Polyethylene Glycols Furans Diterpenes Benzylidene Compounds ATP-Binding Cassette Transporters Piperazines Withanolides Pyrroles Biphenyl Compounds Triazines Vinca Alkaloids Caspase 7 Tubulin Cytochromes c Macrolides Indolizidines Taxoids Platinum Compounds Antimitotic Agents Catechin Ruthenium Compounds Polyphenols Aziridines Topotecan Podophyllotoxin Caspase 9 Pyrimidines Organometallic Compounds Pyridines Teniposide Dioxoles Deoxycytidine Drugs, Chinese Herbal DNA-Binding Proteins Tetrazolium Salts Protein-Serine-Threonine Kinases Vinblastine Flavanones Inhibitor of Apoptosis Proteins Proteasome Endopeptidase Complex NF-kappa B Phenanthrenes Dioxolanes Oxides Phenols Bleomycin Isoquinolines Micelles Cell Cycle Proteins Oligopeptides DNA, Neoplasm Floxuridine Isatin

Analytical, Diagnostic and Therapeutic Techniques and Equipment33

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Inhibitory Concentration 50 Drug Delivery Systems Drug Carriers Drug Design Phytotherapy Drug Evaluation, Preclinical Molecular Targeted Therapy Neoplasm Transplantation Clinical Trials, Phase I as Topic Neoplasms, Experimental Blotting, Western Tumor Burden Drug Discovery Nanocapsules Transplantation, Heterologous Flow Cytometry Antineoplastic Combined Chemotherapy Protocols Melanoma, Experimental Models, Biological Clinical Trials as Topic Models, Molecular Transfection Tumor Stem Cell Assay Molecular Docking Simulation Oncolytic Virotherapy Reverse Transcriptase Polymerase Chain Reaction Genetic Therapy Drug Approval Magnetic Resonance Spectroscopy Subrenal Capsule Assay Chromatography, High Pressure Liquid

Phenomena and Processes41

Apoptosis Drug Resistance, Neoplasm Inhibitory Concentration 50 Cell Proliferation Cell Survival Molecular Structure Drug Synergism Dose-Response Relationship, Drug Cell Cycle Gene Expression Regulation, Neoplastic Drug Resistance, Multiple Signal Transduction Structure-Activity Relationship DNA Damage Cell Cycle Checkpoints Cell Division Cell Death Cell Growth Processes Down-Regulation Membrane Potential, Mitochondrial Particle Size DNA Adducts Time Factors Phosphorylation Enzyme Activation Transfection Autophagy G2 Phase Drug Resistance Genes, MDR G-Quadruplexes Drug Interactions Stereoisomerism DNA Fragmentation Up-Regulation Protein Binding RNA Interference DNA Repair G2 Phase Cell Cycle Checkpoints Mutation Biotransformation

Disciplines and Occupations5

Drug Design Nanomedicine Drug Discovery Chemistry, Pharmaceutical Pharmacogenetics

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture6

Nanomedicine Nanoparticles Nanocapsules Liposomes Polyethylene Glycols Nanostructures

Information Science2

Molecular Docking Simulation Molecular Sequence Data

Health Care2

Clinical Trials, Phase I as Topic Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents Cell Line, Tumor Drug Screening Assays, Antitumor Neoplasms Antineoplastic Agents, Phytogenic Apoptosis Xenograft Model Antitumor Assays Drug Resistance, Neoplasm Inhibitory Concentration 50 Cell Proliferation Doxorubicin Cell Survival Mice, Nude Antibiotics, Antineoplastic Plant Extracts Drug Delivery Systems Tumor Cells, Cultured Molecular Structure Drug Synergism Drug Carriers Cisplatin Drug Design Dose-Response Relationship, Drug Prodrugs Cell Cycle Camptothecin Ellipticines Anticarcinogenic Agents Paclitaxel Etoposide Enzyme Inhibitors Phytotherapy Breast Neoplasms HT29 Cells Gene Expression Regulation, Neoplastic Colonic Neoplasms Drug Resistance, Multiple Nanomedicine Drug Evaluation, Preclinical P-Glycoprotein HCT116 Cells Nanoparticles Signal Transduction Structure-Activity Relationship Topoisomerase I Inhibitors Molecular Targeted Therapy MCF-7 Cells Topoisomerase Inhibitors Caspases Neoplasm Transplantation Tubulin Modulators Lung Neoplasms Caspase 3 DNA Damage Cell Cycle Checkpoints DNA Topoisomerases, Type II Clinical Trials, Phase I as Topic Neoplasms, Experimental Antimetabolites, Antineoplastic Triterpenes Cell Division Cell Death Xanthones Proto-Oncogene Proteins c-bcl-2 Tumor Suppressor Protein p53 Curcumin Blotting, Western Platinum Tumor Burden Histone Deacetylase Inhibitors Coordination Complexes Intercalating Agents Drug Discovery Mice, Inbred BALB C Daunorubicin Angiogenesis Inhibitors Nanocapsules HL-60 Cells Antineoplastic Agents, Alkylating Oplopanax Transplantation, Heterologous Cell Growth Processes Flow Cytometry Drugs, Investigational Stilbenes Fluorouracil Hep G2 Cells Biological Products Naphthoquinones RNA, Small Interfering Reactive Oxygen Species Noscapine Down-Regulation Leukemia P388 Piperidones Organoplatinum Compounds Neoplasm Proteins Prostatic Neoplasms Indoles Benzoquinones

No FAQ available that match "drug anticancer"